A systematic review of economic evaluations of health and health-related interventions in Bangladesh

Cost Effectiveness and Resource Allocation

Volumn 9, Issue , 2011, Pages

  Hoque, Mohammad E ^a   Khan, Jahangir A M ^a   Hossain, Shahed S A ^a   Gazi, Rukhsana ^a   Rashid, Harun Ar ^b   Koehlmoos, Tracey P ^a   Walker, Damian G ^c  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b Bangladesh Medical Research Council   (Bangladesh)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BANGLADESH; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH; HEALTH CARE; HEALTH PROGRAM; HUMAN; INTERVENTION STUDY; MEDLINE; METHODOLOGY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 84860390498     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-9-12     Document Type: Review

References (14)

1. Hoffman C. The influence of economic evaluation studies on decision making: a European survey. Health Policy 2000, 52(3):179-92. 10.1016/S0168-8510(00)00076-2, 10862993.
2. Mills A, Thomas M. Economic Evaluation of Health Programmes in Developing Countries: A Review and Selected Annotated Bibliography. 1984, London School of Hygiene and Tropical Medicine: London.
3. Walker D, Fox-Rushby J. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Economics 2000, 9:681-698. 10.1002/1099-1050(200012)9:8<681::AID-HEC545>3.0.CO;2-X, 11137950.
4. Walker D, Fox-Rushby J. Economic evaluation of parasitic diseases: A critique of the internal and external validity of published studies. Trop Medicine and Int Health 2000, 5:237-249.
5. Iglesias CP, Drummond MF, Rovira J. Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation. Int J of Technol Assess Health Care 2005, 21(1):1-14.
6. Machado M, Iskedjian M, Einarson TR. Quality Assessment of Published Health Economic Analysesfrom South America. Ann Pharmacother 2006, 40:943-9. 10.1345/aph.1G296, 16670369.
7. Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health 2007, 10(1):61-72. 10.1111/j.1524-4733.2006.00145.x, 17261117.
8. Dalzied K, Segal L, Mortimer D. Review of Australian health economics evaluation - 245 interventions: what can be say about cost effectiveness?. Cost Eff Resour Alloc 2008, 6:9. 10.1186/1478-7547-6-9, 2413209, 18489788.
9. Briggs A, Sculpher M. Sensitivity analysis in economic evaluation: a review of published studies. Health Econ 1995, 4:355-371.
10. Udvarhelyi IS, Colditz GA, Rai A, et al. Cost effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?. Ann Intern Med 1992, 116:238-244.
11. Zarnke KB, Levine MA, O'Brien BJ. Cost-benefit analyses in the health-care literature: don't judge a study by its label. J Clin Epidemiol 1997, 50(7):813-822. 10.1016/S0895-4356(97)00064-4, 9253393.
12. Evans DB, Hurley SF. The application of economic evaluation techniques in the health sector: The state of the art. J Int Dev 1995, 7(3):503-524.
13. Mason J, Drummond M. The DH registers of cost effectiveness studies: content and quality. Health Trends 1995, 27:50-56.
14. Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J of Technol Assess Health Care 2005, 21(2):240-245.